ELAN, officially known as ELAN Corporation, is a prominent player in the biotechnology industry, headquartered in Japan (JP). Founded in 1990, the company has established itself as a leader in the development of innovative therapeutics, particularly in the fields of neurology and immunology. With a strong operational presence across Asia and Europe, ELAN focuses on creating unique biopharmaceutical products that address unmet medical needs. The company’s core offerings include advanced drug formulations and delivery systems, which are distinguished by their efficacy and safety profiles. ELAN has achieved significant milestones, including strategic partnerships and successful product launches that have solidified its market position. Renowned for its commitment to research and development, ELAN continues to drive advancements in healthcare, making a meaningful impact on patients' lives worldwide.
How does ELAN's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ELAN's score of 9 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, ELAN reported total carbon emissions of approximately 90,000,000 kg CO2e, with a significant portion attributed to Scope 3 emissions, which totalled about 89,560,000 kg CO2e. Scope 1 emissions were recorded at approximately 609,000 kg CO2e, while Scope 2 emissions amounted to about 314,000 kg CO2e. Currently, ELAN has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. This lack of defined climate commitments may reflect broader industry trends, where many organisations are still developing comprehensive strategies to address climate change. As a company headquartered in Japan, ELAN's emissions profile highlights the importance of establishing clear climate action plans to align with global sustainability goals.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2022 | |
---|---|
Scope 1 | 609,000 |
Scope 2 | 314,000 |
Scope 3 | 89,560,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ELAN is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.